FucT-l Antibodies

Santa Cruz Biotechnology offers a broad range of FucT-l monoclonal antibodies for investigating fucosyltransferase 1 (FucT-l) in various biological processes. FucT-l monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FucT-l is a critical enzyme involved in the fucosylation of glycoproteins and glycolipids, playing a significant role in cell adhesion, signaling, and immune response. The enzyme's function is essential in various physiological and pathological processes, including cancer progression and inflammation. Understanding FucT-l activity can provide insights into disease mechanisms and potential therapeutic targets. Researchers can explore fucosylation pathways through precise detection and analysis of FucT-l expression patterns. Investigating FucT-l localization and interactions helps reveal its regulatory mechanisms in cellular processes. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FucT-l's role in health and disease.